From Professor Anton van der Merwe, Sir William Dunn School of Pathology, University of Oxford, Oxfordshire, UK ...
On January 25, 2025, however, the CIA revised its previous assessment, announcing that it now favored a laboratory-associated ...
For decades, lab-made antibodies have been used to support patients fighting specific diseases. These treatments have become ...
A congressional subcommittee hearing last week scrutinized taxpayer-funded animal testing and gain-of-function research, with ...
The founding director of the FDA’s Office of Biotechnology writes that new evidence suggests COVID may be a novel, additional ...
Titania nanoparticles damage enveloped viruses by directly binding with membrane phospholipids – a previously unknown mode of antiviral action ...
On this day in 2020, the World Health Organization (WHO) named a virus spreading from Wuhan, China, COVID-19. On Feb. 11, ...
President Donald Trump's nominees to run the National Institutes of Health and the Food and Drug Administration are part of a group of scientists censored during the COVID-19 pandemic who are ...
The following is a summary of “Plasma Lipopolysaccharide-Binding Protein (LBP) Is Induced in Critically Ill Females with Gram ...
Observational studies are critical tools in clinical research and public health response, but challenges arise in ensuring ...
The following is a summary of “Multidisciplinary Center Care for Long COVID Syndrome–A Retrospective Cohort Study,” published in the January 2025 issue of Pulmonology by Bailey et al. Researchers ...
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback